Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
Completed · Phase 3
Conditions studied: HIV, HIV Infections
In brief
The primary objective of this study is to evaluate the effect of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) tablet on renal parameters at Week 24 in treatment-naive and treatment-experienced HIV-positive, adults with mild to moderate renal impairment.
Key facts
- Study ID
- NCT01818596
- Run by
- Gilead Sciences
- People needed
- 252
- Starts
- 2013-03-27
- Expected to finish
- 2018-07-18
- Last updated by the study team
- 2020-03-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pueblo Family Physicians — Phoenix, Arizona, United States
- Health for Life Clinic PLLC — Little Rock, Arkansas, United States
- Pacific Oaks Medical Group — Beverly Hills, California, United States
- Kaiser Permanente — Hayward, California, United States
- Long Beach Education and Research Consultants — Long Beach, California, United States
- LA Gay & Lesbian Center - Jeffrey Goodman Special Care Clinic — Los Angeles, California, United States
- Peter J Ruane, MD, Inc — Los Angeles, California, United States
- Anthony Mills MD, Inc — Los Angeles, California, United States
- Desert Medical Group Inc. dba Desert Oasis Healthcare Medical Group — Palm Springs, California, United States
- Kaiser Permanente Medical Group — Sacramento, California, United States
- Metropolis Medical — San Francisco, California, United States
- Kaiser Permanente CTU San Francisco — San Francisco, California, United States
- University of Colorado — Aurora, Colorado, United States
- National Jewish Health — Denver, Colorado, United States
- Dupont Circle Physician's Group — Washington D.C., District of Columbia, United States
- Gary J. Richmond, MD PA — Fort Lauderdale, Florida, United States
- Midway Immunology and Research Center — Ft. Pierce, Florida, United States
- Idocf/Valuhealthmd — Orlando, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Triple O Research Institute, P.A. — West Palm Beach, Florida, United States
- Rowan Tree Medical, P.A. — Wilton Manors, Florida, United States
- Infectious Disease Specialists of Atlanta — Decatur, Georgia, United States
- Mercer University — Macon, Georgia, United States
- Indiana University School of Medicine — Indianapolis, Indiana, United States
- Maricopa Integrated Health System - McDowell Clinic — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.